Further intense research on the pathophysiological involvement of MC in EoE and considering residual MC infiltrations under TCS‐therapy or IL4/IL13 blockade as well as the consideration as an additional therapeutic target could probably influence the course and treatment of EoE. The gene discussed is IL13; the disease is eosinophilic esophagitis.